The core activity of EsoCap Biotech is the development of medical solutions for esophageal diseases. The company focuses on the clinical development of products and technologies to improve the quality of life for patients with esophageal diseases.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered3
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Targeted, long-lasting local application of active substances to the esophagus; capsule-with-film system with mucoadhesive film release and prolonged mucosal contact time.
Lead Indication Development for Eosinophilic Esophagitis
Clinical development of ESO-101 for eosinophilic esophagitis; ACESO Phase II study with mometasone, including safety, tolerability and efficacy data.
Partnering for Development and Manufacturing
Partnerships with biopharma companies, universities and CDMOs for industrial development, manufacture of clinical trial samples and further platform applications.